Cellerant Therapeutics, Inc.
Total Awards:
1
Award Value:
$6,863,755
Institution type:
For profit
Short Name:
Cellerant Therapeutics
Awards to the Institution
| Program Type | Investigator | Grant Title | Award Value |
|---|---|---|---|
| Late Stage Preclinical Projects | Swapna Panuganti | Development of CLT030-ADC, a Leukemic Stem Cell Targeting Antibody-Drug-Conjugate, for Treatment of Acute Myeloid Leukemia | $6,863,755 |
| Total: $6,863,755.00 |
